NASDAQ:BIOS

BioPlus Acquisition (BIOS) Stock Forecast, Price & News

$10.83

-0.01 (-0.09%)

(As of 09/28/2023 ET)

Compare

Today's Range: $10.83
▼
$10.83
50-Day Range: $10.65
▼
$10.84
52-Week Range: $10.05
▼
$11.68

Volume: 327 shs
Average Volume: 126,249 shs
Market Capitalization: $209.78 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Financials Institutional Ownership Headlines SEC Filings Short Interest Social Media

About BioPlus Acquisition (NASDAQ:BIOS) Stock

BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

BIOS Price History

30 days | 90 days | 365 days | Advanced Chart

BIOS Stock News Headlines

August 16, 2023 | finance.yahoo.com

Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring

August 16, 2023 | finance.yahoo.com

Avertix Partners with Institute on Implantable Heart Attack Detection System

September 28, 2023 | Micro-Cap Stock Trader (Ad)

U.S. drive to onshore battery supply chains could create big winners in lithium

Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons

July 20, 2023 | finance.yahoo.com

Avertix Medical Welcomes Renown Cardiologist to Board of Directors

July 17, 2023 | finance.yahoo.com

Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors

June 13, 2023 | finance.yahoo.com

Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando

May 26, 2023 | seekingalpha.com

BIOS BioPlus Acquisition Corp.

May 5, 2023 | msn.com

SPAC BIOS to merge with cardiac device maker Avertix

September 28, 2023 | Micro-Cap Stock Trader (Ad)

Unlock the treasure on Mount Olympus with this little-known mining stock.

Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons

May 3, 2023 | finance.yahoo.com

Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation

March 18, 2023 | money.usnews.com

BioPlus Acquisition Corp - Ordinary Shares - Class A

September 23, 2022 | wsj.com

BioPlus Acquisition Corp. Cl A

September 20, 2022 | finance.yahoo.com

BioPlus Acquisition Corp. (BIOS)

September 3, 2022 | investing.com

BioPlus Acquisition Corp (BIOS)

August 13, 2022 | reuters.com

BioPlus Acquisition Corp

August 10, 2022 | finance.yahoo.com

What Type Of Shareholders Own The Most Number of BioPlus Acquisition Corp. (NASDAQ:BIOS) Shares?

See More Headlines

Receive BIOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BIOS Company Calendar

Today: 9/28/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Holding & other investment offices
Sub-Industry: N/A
Sector: Unclassified
Current Symbol: NASDAQ:BIOS
CUSIP: N/A
CIK: 1856653
Web: bioplusspac.com
Phone: 212-287-4092
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 19,370,000
Free Float: 14,990,000
Market Cap: $209.78 million
Optionable: Not Optionable
Beta: 0.02

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. Jonathan M. N. Rigby MBA (Age 55)
Chairman & Chief Bus. Officer

Mr. R. Ross Haghighat (Age 59)
CEO, CFO & Director

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

BIOS Stock - Frequently Asked Questions

How have BIOS shares performed in 2023?: BioPlus Acquisition's stock was trading at $10.22 on January 1st, 2023. Since then, BIOS stock has increased by 6.0% and is now trading at $10.83.
View the best growth stocks for 2023 here.
Are investors shorting BioPlus Acquisition?: BioPlus Acquisition saw a decline in short interest in September. As of September 15th, there was short interest totaling 1,600 shares, a decline of 36.0% from the August 31st total of 2,500 shares. Based on an average daily trading volume, of 40,000 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the company's shares are short sold.
View BioPlus Acquisition's Short Interest.
What ETF holds BioPlus Acquisition's stock ?: CrossingBridge Pre-Merger SPAC ETF holds 29,741 shares of BIOS stock, representing 0.48% of its portfolio.
When did BioPlus Acquisition IPO?: (BIOS) raised $180 million in an IPO on Friday, December 3rd 2021. The company issued 18,000,000 shares at a price of $10.00 per share. Cantor acted as the underwriter for the IPO.

What is BioPlus Acquisition's stock symbol?: BioPlus Acquisition trades on the NASDAQ under the ticker symbol "BIOS."
Who are BioPlus Acquisition's major shareholders?: BioPlus Acquisition's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Westchester Capital Management LLC (4.74%), Mizuho Securities USA LLC (3.46%), Radcliffe Capital Management L.P. (2.45%), Berkley W R Corp (2.04%), Wolverine Asset Management LLC (1.65%) and Quarry LP (1.55%).
How do I buy shares of BioPlus Acquisition?: Shares of BIOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is BioPlus Acquisition's stock price today?: One share of BIOS stock can currently be purchased for approximately $10.83.
How much money does BioPlus Acquisition make?: BioPlus Acquisition (NASDAQ:BIOS) has a market capitalization of $209.78 million.
How can I contact BioPlus Acquisition?: BioPlus Acquisition's mailing address is 260 MADISON AVENUE SUITE 800, NEW YORK NY, 10016. The official website for the company is bioplusspac.com. The company can be reached via phone at 212-287-4092.

This page (NASDAQ:BIOS) was last updated on 9/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial